InvestorsHub Logo
Followers 44
Posts 773
Boards Moderated 0
Alias Born 08/25/2020

Re: None

Wednesday, 08/03/2022 1:16:05 PM

Wednesday, August 03, 2022 1:16:05 PM

Post# of 198264
The easiest thing to do is listen to the remarks from the patent attorney and establish a realistic time line for them to go public with all the developments. The disclosure on test results or technical data can risk the awarding of an exclusive patent for the discoveries. Maybe if someone can decipher when they applied for the patent for the HIV conserved sights on the virus as well as approximately how long it took for that patent to be secured. That should give you a solid timeline as to how long it should take for the patents to be awarded for the numerous other filings they've submitted. I believe Charles referenced the info that they should be awarded the same protections for covid as well as the other viruses in the not to distant future. That will open them up to discuss the deals they are putting in place now without jeopardizing the patents being awarded in the future for the other viruses. This doesn't mean that they're not already in clinical trials or have not completed the testing and manufacturing necessary to move forward. They just can't disclose the results at this time. They can however choose to discuss the results with potential partners and move forward under the NDAs. to continue to work on bringing the products to market. This company is run by an attorney who remembers what he's learned. Be extra cautious until everything is locked up. The attorney running the company would not allow the officers to publish or release unofficial or factually inaccurate information at this crucial time. If any member of the company misled the general investing public. That would be a huge problem. This journey has almost reached the end goal. The longs should not have a problem waiting this out. You've waited long enough already!! Covid is going to jump u[p going into the cold and flu season. Whatever info/news they have on that front will be released out of necessity prior to that happening. I still find it unusual that Reg has not put out any information on the reinstatement of their Monoclonal Antibody therapeutic treatment that they were looking to get approval for reissuance or use. It was coincidental that the advisory board member from ENZC was going to be on the interview and that the specialty of this person was assisting in getting pharmaceutical products to market. Was it coincidence that the hashtag special situation or EUA was put out there numerous times. I feel that you will here nothing until the patent is awarded for covid monoclonal antibodies. Then the cat will be let out of the bag. I do think the share price is being manipulated in a weird way that appears to be more protective than malicious now. I wonder who could of been getting shares or how financing could've been taking place through that process. The continued negative forces around ENZC appear to be going into overdrive. Clearly one of the NDAS has to cover IPF in some way. No company would be that far along to bringing a product to market and than silence on that product. That product may have been part of a deal that gives partial or complete ownership over that product to a new partner. Maybe they were working on getting rights to that product world wide. I for one am not going anywhere. I hope the longs see that this is not the usual stock. I think it would be a complete joke if a fake company went through all the trouble to file applications for numerous immutable sights on viruses to just be a scam. This company is the unicorn that everyone believes it is. Just remember that Unicorns take time to learn to fly. This company will be flying sin short order. Ignore the negative desperate attacks you see on this company. It should reaffirm that you are in the correct place at almost the perfect time.